DEEPMATTER, the digital chemistry specialist, has signed a contract with a major pharmaceuticals manufacturer in India to provide its real-time “recipes” platform.
Glasgow-based DeepMatter will provide its DigitalGlassware platform to Dr Reddy’s process development team who are looking to the development and scale-up of chemistry procedures to handover to colleagues.
The collaboration is part of DeepMatter’s ongoing strategy to provide its platform to the major global contract research organisations (CROs) where the need for reproducibility is central to accelerating the discovery of new drugs.
Dr Reddy’s manufactures and markets a wide range of pharmaceuticals in India and overseas and has built strong R&D capabilities worldwide, making it a partner of choice in contract research, development, and manufacturing services.
DigitalGlassware comprises a cloud-based software platform allowing scientists to easily bring together digitised synthesis protocols – recipes – and contextualised time-course sensor streams from a range of analytical instrumentation, importantly in real-time.
Mark Warne, DeepMatter Group chief executive, said it is focused on creating value for the world’s largest CROs with the platform as it constantly builds on its capabilities.
“We are working with them to firmly establish it as the go-to platform for capturing and structuring time-course sensor data in the lab, to enable improved insights for better productivity and discovery,” he said.
“Dr Reddy’s are actively interested in the capture of parameters that they can utilise for their process development and modelling activities.”